Metoprolol Egis

Metoprolol Tartrate, the active ingredient in Metoprolol Egis, is a beta blocker presented as an oral tablet for oral use. It is used to manage high blood pressure, chest pain, and certain heart‑failure conditions in adult patients. GNH USA supplies Metoprolol Egis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoprolol Egis is a selective β1‑adrenergic blocker indicated for several cardiovascular conditions. - Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain episodes. - Post‑myocardial infarction: improves survival by reducing arrhythmic events and cardiac workload. - Chronic heart failure: enhances ventricular function and reduces hospitalisations.

Metoprolol Egis may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Fatigue or tiredness - Dizziness or light‑headedness - Cold extremities (hands and feet) - Gastrointestinal upset (nausea, abdominal discomfort)

Serious or Rare Side Effects: - Severe bradycardia or heart block - Marked hypotension - Bronchospasm, especially in patients with asthma or COPD - Allergic reactions such as rash, angioedema, or anaphylaxis

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for adverse events. - Blood pressure monitoring: ensure adequate control without excessive hypotension. - Cardiac function assessment: use caution in patients with existing heart block or severe heart failure. - Respiratory caution: avoid in uncontrolled asthma or severe chronic obstructive pulmonary disease. - Renal/hepatic impairment: dose adjustments may be required in reduced clearance. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Metoprolol Egis can interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - Combined use with other AV‑node blockers (e.g., verapamil, diltiazem) may cause profound bradycardia. - Abrupt discontinuation of clonidine while on Metoprolol can precipitate hypertensive crisis. - Concurrent insulin or oral hypoglycemics may mask hypoglycaemia symptoms. - NSAIDs may diminish antihypertensive effect, leading to uncontrolled blood pressure.

Moderate Interactions (Monitor Closely): - Calcium‑channel blockers (non‑dihydropyridines) may enhance negative chronotropic effects. - Diuretics can potentiate hypotensive response. - Certain antidepressants (e.g., SSRIs) may increase plasma concentrations of Metoprolol.